EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Prolonged Detection of GHB Intake in Urine: Are We Finally There?

Kathrine B Faldborg iD, Jørgen B Hasselstrøm, Thomas Kraemer, Charlotte U Andersen, Andrea E Steuer iD

Drug Testing and Analysis · 2025-12 · 17 (12) · 2429-2446

DOI: 10.1002/dta.3956 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Testing and Analysis, online erschienen am 06.10.2025. Verfasst von Kathrine B Faldborg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Hydroxybutyrates, Substance Abuse Detection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Council of the Danish Victims Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gamma‐hydroxybutyric acid (GHB) has been implicated in drug‐facilitated sexual assault (DFSA). However, due to its rapid elimination and the challenge of distinguishing exogenous from endogenous levels, GHB is likely to be significantly underestimated in DFSA cases. Consequently, previous research has focused on identifying biomarkers associated with GHB intake that persist longer than GHB itself. Conjugates of GHB with amino acids and pentose have been proposed as potential candidates, but data on their detection times remain limited. In this study, a randomised, placebo‐controlled trial involving 30 healthy volunteers was conducted. Urine samples were collected at regular intervals over 5 days post‐administration. Using a validated LC‐MS/MS method, we quantified known and proposed GHB biomarkers, aiming to identify those capable of extending the detection window. GHB–amino acid conjugates showed limited utility beyond early time points, whereas a tentatively identified GHB‐pentose emerged as a very promising marker. With structural confirmation and further validation, it may allow reliable detection for at least 24 h after intake, representing a significant advance in DFSA investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxybutyratesSubstance Abuse DetectionHumansTandem Mass SpectrometryAdultBiomarkersMaleYoung AdultFemaleChromatography, LiquidTime FactorsAmino Acids

Substanzen

Hydroxybutyrates4-hydroxybutyric acidBiomarkersAmino Acids

Autor:innen und Institutionen

  • Department of Forensic Medicine, Aarhus University, Aarhus, Denmark.
  • Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Kathrine B Faldborg, Andrea E Steuer

Förderung

  • Council of the Danish Victims Fund

Zitieren

APA

Faldborg, K. B., Hasselstrøm, J. B., Kraemer, T., Andersen, C. U., & Steuer, A. E. (2025). Prolonged Detection of GHB Intake in Urine: Are We Finally There?. Drug Testing and Analysis, 17(12), 2429-2446. https://doi.org/10.1002/dta.3956

Vancouver

Faldborg KB, Hasselstrøm JB, Kraemer T, Andersen CU, Steuer AE. Prolonged Detection of GHB Intake in Urine: Are We Finally There?. Drug Testing and Analysis. 2025;17(12):2429-2446. doi:10.1002/dta.3956

BibTeX
@article{Faldborg2025,
  author = {Faldborg, Kathrine B and Hasselstrøm, Jørgen B and Kraemer, Thomas and Andersen, Charlotte U and Steuer, Andrea E},
  title = {Prolonged Detection of GHB Intake in Urine: Are We Finally There?},
  journal = {Drug Testing and Analysis},
  year = {2025},
  volume = {17},
  number = {12},
  pages = {2429--2446},
  doi = {10.1002/dta.3956}
}
Kostenlos starten →